{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:36:49Z","timestamp":1774251409991,"version":"3.50.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Posttraumatic stress disorder (PTSD) is associated with elevated inflammation and risk for chronic illness, yet few studies have examined inflammatory biomarker outcomes of PTSD interventions. Rapid PTSD symptom reduction has been observed following 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy, which leverages MDMA as a prosocial adjunct to psychotherapy. No studies have evaluated inflammatory biomarker outcomes of MDMA-assisted therapy. This exploratory pilot study examined within-person changes in inflammatory biomarkers during MDMA-assisted group therapy for Veterans with PTSD (\n                      <jats:ext-link>www.clinicaltrials.gov<\/jats:ext-link>\n                      , NCT05961527).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood plasma samples were collected from 23 Veterans at baseline and end-of-intervention. Hedges\u2019 g effect sizes were calculated for interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-\u03b1), and C-reactive protein (CRP). PTSD severity was assessed with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at baseline and 30-day follow-up. Spearman\u2019s rho correlations were calculated among biomarkers, PTSD symptoms, and change scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Small increases were observed in IL-6 (\n                      <jats:italic>g<\/jats:italic>\n                      = 0.24; 95% CI \u20130.25, 0.72) and CRP (\n                      <jats:italic>g<\/jats:italic>\n                      = 0.23; 95% CI \u20130.30, 0.74), and a small decrease in TNF-\u03b1 (\n                      <jats:italic>g<\/jats:italic>\n                      = \u20130.24; 95% CI \u20130.69, 0.23). Baseline IL-6 and TNF-\u03b1 were positively associated with baseline CAPS-5 scores (\u03c1 = 0.45, 0.32). Higher baseline IL-6 weakly predicted symptom improvement (\u03c1 = \u20130.25), and IL-6 change correlated with symptom change (\u03c1 = 0.41). CRP showed weak negative associations with PTSD symptoms (\u03c1 = \u20130.26).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Findings suggest MDMA-assisted therapy may modulate inflammatory biomarkers and highlight biomarker\u2013symptom relationships. Results are preliminary but may inform larger studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2026.1716817","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:42:52Z","timestamp":1774248172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study"],"prefix":"10.3389","volume":"20","author":[{"given":"Jenna E.","family":"Kachmarik","sequence":"first","affiliation":[{"name":"VA Portland Health Care System","place":["Portland, OR, United States"]},{"name":"Department of Psychiatry, Oregon Health and Science University","place":["Portland, OR, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Loftis","sequence":"additional","affiliation":[{"name":"VA Portland Health Care System","place":["Portland, OR, United States"]},{"name":"Department of Psychiatry, Oregon Health and Science University","place":["Portland, OR, United States"]},{"name":"Department of Behavioral Neuroscience, Oregon Health and Science University","place":["Portland, OR, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Stauffer","sequence":"additional","affiliation":[{"name":"VA Portland Health Care System","place":["Portland, OR, United States"]},{"name":"Department of Psychiatry, Oregon Health and Science University","place":["Portland, OR, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/jep.13386","article-title":"Mental health is the health of the whole body: How psychoneuroimmunology & health psychology can inform & improve treatment.","volume":"26","author":"Alessi","year":"2020","journal-title":"J. Eval. Clin. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1476-5381.2010.00899.x","article-title":"Methylenedioxymethamphetamine (\u2018Ecstasy\u2019)-induced immunosuppression: A cause for concern?","volume":"161","author":"Boyle","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jpsychires.2025.09.080","article-title":"Evaluation of undiagnosed depression and inflammatory markers in volunteers submitted to a health questionnaire.","volume":"191","author":"Camillo","year":"2025","journal-title":"J. Psychiatr. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e027925","DOI":"10.1136\/bmjopen-2018-027925","article-title":"Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder.","volume":"9","author":"Costello","year":"2019","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters.","volume":"70","author":"Del Giudice","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/ijerph20042937","article-title":"Metabolic and inflammatory response in post-traumatic stress disorder (PTSD): A systematic review on peripheral neuroimmune biomarkers.","volume":"20","author":"Dell\u2019Oste","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1567-7443(07)00201-3","article-title":"The HPA axis and the immune system.","volume":"7","author":"Dunn","year":"2007","journal-title":"Neuroimmune Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jts.21956","article-title":"Prevalence of a positive screen for PTSD among OEF\/OIF and OEF\/OIF-Era veterans in a large population-based Cohort.","volume":"27","author":"Dursa","year":"2014","journal-title":"J. Trauma. Stress"},{"key":"B9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","article-title":"Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.","volume":"71","author":"Eraly","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1093\/med-psych\/9780190926939.001.0001","volume-title":"Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences: Therapist Guide","author":"Foa","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s43440-025-00782-x","article-title":"The cortisol axis and psychiatric disorders: An updated review.","volume":"77","author":"George","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jpsychores.2012.10.013","article-title":"Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls.","volume":"74","author":"Gill","year":"2013","journal-title":"J. Psychosom. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00011-011-0308-7","article-title":"Impact of smoking on inflammation: Overview of molecular mechanisms.","volume":"60","author":"Gon\u00e7alves","year":"2011","journal-title":"Inflamm. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.cpnec.2021.100052","article-title":"How to deal with non-detectable and outlying values in biomarker research: Best practices and recommendations for univariate imputation approaches.","volume":"7","author":"Herbers","year":"2021","journal-title":"Compr. Psychoneuroendocrinol."},{"key":"B16","first-page":"293","article-title":"Serum concentrations of TNF-\u03b1 and its soluble receptors during psychotherapy in German soldiers suffering from combat-related PTSD.","volume":"28","author":"Himmerich","year":"2016","journal-title":"Psychiatr. Danub."},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/pcn.12820","article-title":"Inflammation and post-traumatic stress disorder.","volume":"73","author":"Hori","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0269881120965915","article-title":"A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.","volume":"35","author":"Illingworth","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1002\/sim.6564","article-title":"Designing a study to evaluate the benefit of a biomarker for selecting patient treatment.","volume":"34","author":"Janes","year":"2015","journal-title":"Stat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107406","DOI":"10.1016\/j.psyneuen.2025.107406","article-title":"Exploring the dissociative subtype of PTSD: The role of early-life trauma, cortisol, and inflammatory profiles.","volume":"175","author":"Jarkas","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpsychires.2021.01.039","article-title":"Functional impairment in posttraumatic stress disorder: A systematic review and meta-analysis.","volume":"136","author":"Jellestad","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41398-022-02094-7","article-title":"The role of the immune system in posttraumatic stress disorder.","volume":"12","author":"Katrinli","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e22711","DOI":"10.7759\/cureus.22711","article-title":"Obesity: A chronic low-grade inflammation and its markers.","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejpsy.2017.09.005","article-title":"Psychiatric comorbidity and PTSD-related health problems in war veterans: Cross-sectional study.","volume":"31","author":"Klaric","year":"2017","journal-title":"Eur. J. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs.","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.bbih.2024.100849","article-title":"Post traumatic stress disorder associated hypothalamic-pituitary-adrenal axis dysregulation and physical illness.","volume":"41","author":"Lawrence","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.focus.20220088","article-title":"A review of MDMA-assisted therapy for posttraumatic stress disorder.","volume":"21","author":"Lewis","year":"2023","journal-title":"Focus"},{"key":"B28","doi-asserted-by":"publisher","first-page":"959590","DOI":"10.3389\/fpsyt.2023.959590","article-title":"Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD.","volume":"14","author":"Lewis","year":"2023","journal-title":"Front. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2494480","DOI":"10.1080\/20008066.2025.2494480","article-title":"Causal relationship between inflammatory cytokines and posttraumatic stress disorder: A Mendelian randomization study and potential mechanism analysis.","volume":"16","author":"Li","year":"2025","journal-title":"Eur. J. Psychotraumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","article-title":"The longitudinal associations of inflammatory biomarkers and depression revisited: Systematic review, meta-analysis, and meta-regression.","volume":"26","author":"Mac Giollabhui","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbi.2025.01.001","article-title":"C-reactive protein as a possible indicator of PTSD prognosis and comorbid anhedonia.","volume":"125","author":"Madison","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2021.12.025","article-title":"The relations between C-reactive protein and trauma exposure, PTSD and depression symptoms, and PTSD psychotherapy treatment response in treatment seeking veterans and service members.","volume":"101","author":"Maples-Keller","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and Beyond.","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study.","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial.","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"key":"B36","unstructured":"Mithoefer\n              M. C.\n            \n            \n              Mithoefer\n              A. T.\n            \n            \n              Jerome\n              L.\n            \n            \n              Ruse\n              J.\n            \n            \n              Gibson\n              E.\n            \n            \n              Ot\u2019alora\n              M. G.\n            \n          \n          A Manual for MDMA-assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder. Multidisciplinary Association for Psychedelic Studies (MAPS).\n          \n          2017"},{"key":"B37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.biopsych.2014.06.015","article-title":"Elevated risk for autoimmune disorders in Iraq and afghanistan veterans with posttraumatic stress disorder.","volume":"77","author":"O\u2019Donovan","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbi.2010.10.003","article-title":"A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities.","volume":"25","author":"Pace","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100542","DOI":"10.1016\/j.bbih.2022.100542","article-title":"MDMA administration attenuates hippocampal IL-\u03b2 immunoreactivity and subsequent stress-enhanced fear learning: An animal model of PTSD.","volume":"26","author":"Parekh","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression.","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41398-022-02230-3","article-title":"Pro- and anti-inflammatory cytokines Interleukin-6 and Interleukin-10 predict therapy outcome of female patients with posttraumatic stress disorder.","volume":"12","author":"Renner","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B42","volume-title":"Cognitive Processing Therapy for PTSD: A Comprehensive Therapist Manual","author":"Resick","year":"2024"},{"key":"B43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00702-024-02770-6","article-title":"Paradoxical effect of anti-inflammatory drugs on IL-6 mRNA expression in patients with PTSD during treatment.","volume":"131","author":"Rhein","year":"2024","journal-title":"J. Neural Transm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00702-021-02346-8","article-title":"Interleukin-6 secretion upon acute psychosocial stress as a potential predictor of psychotherapy outcome in posttraumatic stress disorder.","volume":"128","author":"Rhein","year":"2021","journal-title":"J. Neural Transm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/154733251903100412","article-title":"Changes in inflammatory biomarkers before and after SSRI Therapy in PTSD: A review.","volume":"31","author":"Sagarwala","year":"2019","journal-title":"Ann. Clin. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1007\/s12671-022-01969-6","article-title":"Biomarker response to mindfulness intervention in veterans diagnosed with post-traumatic stress disorder.","volume":"13","author":"Shapira","year":"2022","journal-title":"Mindfulness"},{"key":"B47","volume-title":"Written Exposure Therapy for PTSD: A Brief Treatment Approach for Mental Health Professionals.","author":"Sloan","year":"2019"},{"key":"B48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress.","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues in Clin. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpsychires.2009.06.002","article-title":"Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: Evidence from the general population.","volume":"44","author":"Spitzer","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cbpra.2025.03.001","article-title":"MDMA-assisted group therapy for PTSD: Development of a novel protocol.","volume":"32","author":"Stauffer","year":"2025","journal-title":"Cogn. Behav. Pract."},{"key":"B51","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopsych.2019.11.005","article-title":"Posttraumatic stress disorder and inflammation: Untangling issues of bidirectionality.","volume":"87","author":"Sumner","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2147\/NDT.S173659","article-title":"PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress.","volume":"14","author":"Toft","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B53","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.bbih.2023.100620","article-title":"Peripheral inflammation over the course of a cognitive behavioral intervention in PTSD.","volume":"30","author":"von Majewski","year":"2023","journal-title":"Brain Behav. Immun. Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The clinician-administered PTSD scale for DSM\u20135 (CAPS-5): Development and initial psychometric evaluation in military veterans.","volume":"30","author":"Weathers","year":"2018","journal-title":"Psychol. Assess."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1354229","DOI":"10.3389\/fpsyg.2024.1354229","article-title":"The assessment of reliability generalisation of clinician-administered PTSD scale for DSM-5 (CAPS-5): A meta-analysis.","volume":"15","author":"Wojujutari","year":"2024","journal-title":"Front. Psychol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jad.2020.02.044","article-title":"Immune biomarkers alterations in post-traumatic stress disorder: A systematic review and meta-analysis.","volume":"268","author":"Yang","year":"2020","journal-title":"J. Affect. Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e70633","DOI":"10.1002\/brb3.70633","article-title":"Research progress on inflammation and immune dysregulation in PTSD.","volume":"15","author":"Yang","year":"2025","journal-title":"Brain Behav."},{"key":"B58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12888-023-04765-1","article-title":"Sleep characteristics and inflammatory markers in women with post-traumatic stress disorder.","volume":"23","author":"Yeh","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.bbii.2023.100031","article-title":"Effects of group trauma-sensitive yoga on inflammatory markers and psychological well-being in women veterans with PTSD: A randomized controlled trial.","volume":"4","author":"Zaccari","year":"2023","journal-title":"Brain Behav. Immun. Integr."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1716817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:42:55Z","timestamp":1774248175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1716817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":59,"alternative-id":["10.3389\/fnins.2026.1716817"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1716817","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1716817"}}